Physician Assistant · New York, NY
NPI
1881241610
Since 2019
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1470 Madison Ave
New York, NY, 10029
Phone (212) 241-6756
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.9M
336 prescriptions
Company payments, 2025
$1,038
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Emina Begovic prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 108 prescriptions and refills. In total Emina Begovic wrote 336 Medicare prescriptions that cost $3.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Jakafi Ruxolitinib Phosphate | 108 | 110 | 27 | $1.9M |
| Hydroxyurea Generic | 46 | 63 | 14 | $385 |
| Gleevec Imatinib Mesylate | 19 | 19 | Under 11 | $135K |
| Vonjo Pacritinib Citrate | 16 | 20 | Under 11 | $424K |
| Atovaquone Generic | 15 | 16 | Under 11 | $12K |
| Inqovi Decitabine/Cedazuridine | 13 | 13 | Under 11 | $109K |
| Imatinib Mesylate Generic | 12 | 12 | Under 11 | $2,269 |
| Inrebic Fedratinib Dihydrochloride | 11 | 11 | Under 11 | $297K |
Brand drugs: 217 claims; generic drugs: 119 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emina Begovic $1,038 ($1,038 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $247.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $247 |
| Celgene Corporation BMY | 6 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $139 |
| Blueprint Medicines Corporation SNY | 4 | $126 |
| Genzyme Corporation SNY | 3 | $102 |
| GlaxoSmithKline, LLC. GSK | 3 | $62.59 |
| Napo Pharmaceuticals Inc | 2 | $59.58 |
| Stemline Therapeutics Inc. | 2 | $44 |
| Daiichi Sankyo Inc. 4568.T | 1 | $28.39 |
| Azurity Pharmaceuticals, Inc. | 1 | $27.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.